Delisting riskPopularity #4,494
BIOX · NASDAQ · Agricultural Inputs

Bioceres Crop Solutions (BIOX)

Commercializes seed, microbial, nutrition, and crop-protection products for agricultural production.

$0.3534
vs last close−0.01 (−1.81%)
Loading prices…

Bioceres Crop Solutions Corp.BIOX
Materials

Commercializes seed traits, microbial agricultural inputs, crop-nutrition products, and crop-protection products. An Argentine grower-founded platform, it now focuses its continuing operations on Crop Protection, Crop Nutrition, and Seed and Integrated Products.

Commercializes seed traits, microbial agricultural inputs, and crop-input products from an Argentina-centered operating base. The portfolio includes patented seed and microbial technologies and the HB4 program's digital and traceability tools.

Founded in Argentina by farmers and agronomists, the platform expanded its product lines through the controlling Rizobacter acquisition. Its business lines are Seed and Integrated Products, Crop Protection, and Crop Nutrition.

The current continuing business now excludes the foreclosed Pro Farm activities in the United States and Europe. Its current structure remains shaped by that discontinuation and an Argentina-centered focus.

Company facts

CEOFederico Trucco, Ph.D.
ListedMar 14, 2019
ExchangeNASDAQ
HeadquartersRosario, Argentina
CountryArgentina
Employees751
CIK0001769484
ISINKYG1117K1141

Market cap$22.8M
EPS (ttm)−$3.58
P/E (ttm)−0.1005
ROE-216.1%
P/B0.5820
P/S0.0924
Dividend yieldDiv yield
Beta1.71vs XLB 0.10

Price target$5.00+1,288.9%Average of 5 analysts
ConsensusBuy4 of 5 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Jan 2, 2026Canaccord GenuityReiterate
Rating: Target: $2.50
Rating: HoldTarget: $2
Sep 10, 2025Canaccord GenuityDowngrade
Rating: BuyTarget: $12.50
Rating: HoldTarget: $2.50

Next report
Nov 12, 26
estimated · in 50 days
EPS estimate
Revenue estimate
Fiscal quarter
Q1 FY27

EPSReportedEstimate

Feb '25May '25Sep '25Nov '25Mar '26May '26Sep '26Nov '26
Reported$0.01−$0.02−$0.70−$0.12−$0.08−$0.16−$0.39Pending
Estimate$0.14−$0.10$0.10−$0.04$0.07−$0.05−$0.06
Surprise−93.2%+80.0%−800.0%−200.0%−214.3%−220.0%−542.0%

RevenueReportedEstimate

Feb '25May '25Sep '25Nov '25Mar '26May '26Sep '26Nov '26
Reported$106.7M$60.6M$74.7M$77.5M$73.7M$39.4M$55.9MPending
Estimate$123.9M$63.0M$110.1M$94.6M$96.0M$54.5M$79.0M
Surprise−13.9%−3.7%−32.1%−18.1%−23.3%−27.7%−29.2%
Estimate
ReportedDue Nov 12, 2026
Estimate
ReportedDue Nov 12, 2026
View details

Debt to equity605.60%
Current ratio80.60%

ProfitabilityRevenueNet incomeNet margin

Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue$92.6M$98.9M$59.6M$74.4M$77.4M$73.7M$38.2M$57.0M
Net income−$6.4M$143.5K−$1.3M−$47.9M−$7.3M−$183.0M−$12.3M−$27.5M
Net margin0.0%0.1%0.0%0.0%0.0%0.0%0.0%0.0%

GrowthOperating income

Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Operating income$3.7M$15.2M$933.2K−$6.9M$7.8M$7.8M−$6.5M−$10.1M
YoY growth−30.8%−9.6%−92.9%Turned loss+111.8%−48.5%Turned lossLoss widened

Balance sheet, Jun 30, 2026Cash & short-term investments $12.2M · Total debt $236.8M · Total assets $471.3M · Shareholders' equity $39.1M

Revenue
$57.0M
Operating income
−$10.1M
Net income
−$27.5M
View details

No dividends on record.

Institutions13.32%8.42M shares
30 holders · as of Jun 30, 2026
Insiders0.86%542.1K shares
3 holders · as of Aug 10, 2026
Strategic holders9.91%6.27M shares
1 holder · as of Oct 28, 2025
Other75.91%48.00M shares
remainder

63.23M company shares as of Aug 25, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Bioceres Group PLCStrategic
9.91%6.27Mfiled Oct 28, 2025
Solel Partners LPInstitution
7.24%4.58Mas of Jun 30, 2026
Fourth Sail Capital LPInstitution
6.85%4.33Mfiled Jan 21, 2026
Mirae Asset Global Etfs Holdings Ltd.Institution
2.22%1.41Mas of Jun 30, 2026
Long Focus Capital Management, LLCInstitution
1.31%829,748as of Jun 30, 2026

Insider tradesForm 4

No open-market trades in the last 12 months.

View details

  • Corteva

    Seeds, traits, crop protection and biological inputs for row crops

  • FMC

    Crop-protection biologicals, seed treatments and microbial crop inputs

Compare

CompanyPriceChange
Bioceres Crop Solutions$0.3534−1.81%$22.8M0.1−25.2%
Corteva$81.83+1.85%$53.69B53.220.83.0−1.2%
FMC$10.22−3.31%$1.32B7.20.4−17.5%
Median53.214.01.7−9.3%